SANGAMO THERAPEUTICS INC's ticker is SGMO and the CUSIP is 800677106. A total of 115 filers reported holding SANGAMO THERAPEUTICS INC in Q4 2013. The put-call ratio across all filers is 0.10 and the average weighting 0.7%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2014 | $4,853,000 | -29.4% | 450,000 | 0.0% | 0.66% | -23.9% |
| Q2 2014 | $6,871,000 | -15.5% | 450,000 | 0.0% | 0.87% | -3.4% |
| Q1 2014 | $8,136,000 | -65.4% | 450,000 | -73.4% | 0.90% | -64.3% |
| Q4 2013 | $23,535,000 | +30.6% | 1,694,401 | -1.5% | 2.52% | +14.1% |
| Q3 2013 | $18,019,000 | +30.8% | 1,719,401 | -2.5% | 2.21% | +19.1% |
| Q2 2013 | $13,773,000 | – | 1,763,503 | – | 1.86% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Alexandria Capital, LLC | 1,003,725 | $15,663,000 | 1.66% |
| Golden State Equity Partners | 123,817 | $1,932,000 | 1.33% |
| Rhenman & Partners Asset Management AB | 821,888 | $12,826,000 | 1.05% |
| WASATCH ADVISORS LP | 10,072,381 | $157,180,000 | 0.77% |
| BOGLE INVESTMENT MANAGEMENT L P /DE/ | 29,636 | $462,000 | 0.73% |
| Ceeto Capital Group, LLC | 80,000 | $1,248,000 | 0.63% |
| EMC Capital Management | 48,992 | $765,000 | 0.58% |
| Fort Sheridan Advisors LLC | 71,173 | $1,111,000 | 0.54% |
| Vanguard Capital Wealth Advisors | 34,680 | $584,000 | 0.54% |
| Casdin Capital, LLC | 1,080,000 | $16,853,000 | 0.50% |